![Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties | PNAS Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties | PNAS](https://www.pnas.org/cms/10.1073/pnas.1901734117/asset/3df9a166-9499-4800-a9f7-49e5fac85081/assets/graphic/pnas.1901734117fig01.jpeg)
Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties | PNAS
![PDF] Assessment of monoclonal gammopathies by nephelometric measurement of individual immunoglobulin kappa/lambda ratios. | Semantic Scholar PDF] Assessment of monoclonal gammopathies by nephelometric measurement of individual immunoglobulin kappa/lambda ratios. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c28d1869d8b2fbdcbec72aba911a0739211e7e46/7-Table2-1.png)
PDF] Assessment of monoclonal gammopathies by nephelometric measurement of individual immunoglobulin kappa/lambda ratios. | Semantic Scholar
![Frontiers | Significant Differences in Physicochemical Properties of Human Immunoglobulin Kappa and Lambda CDR3 Regions Frontiers | Significant Differences in Physicochemical Properties of Human Immunoglobulin Kappa and Lambda CDR3 Regions](https://www.frontiersin.org/files/Articles/219574/fimmu-07-00388-HTML-r1/image_m/fimmu-07-00388-g004.jpg)
Frontiers | Significant Differences in Physicochemical Properties of Human Immunoglobulin Kappa and Lambda CDR3 Regions
![Immunoglobulin kappa deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCR | Leukemia Immunoglobulin kappa deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCR | Leukemia](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fsj.leu.2402475/MediaObjects/41375_2002_Article_BF2402475_Fig2_HTML.jpg)